GALT (Galectin Therapeutics, Inc.) Rega marang bathi mangsa ngarep

Galectin Therapeutics (GALT) focuses on developing innovative treatments to combat liver fibrosis, with the key metric standing at 0.00. This chart illustrates a price trend that reflects the asset's dynamics amid a lack of stable revenue and a reliance on existing capital reserves. Patent protection for carbohydrate compounds and stringent FDA requirements create significant barriers to entry for new players in this segment.

GALT - Kapitalisasi marang proyeksi bathi Galectin Therapeutics Inc. ing rentang 04.07.2022 - 14.11.2026

Ringkesan rincian data analitis Galectin (GALT)

- rega saiki lan proyeksi nilai saham:

Kutipan saham Galectin Therapeutics|GALT - Konsensus nilai wajar

- indikator valuasi pasar bisnis:

Nilai pasar Galectin Therapeutics, Inc.|GALT - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Nilai Buku saben Saham Galectin Therapeutics|GALT - Pambiji Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih galectintherapeutics.com|GALT - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

Total Utang marang Modal Galectin Therapeutics|GALT - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Galectin Therapeutics|GALT - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Galectin Therapeutics, Inc.|GALT - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Galectin Therapeutics|Likuiditas cepet galectintherapeutics.com

- statistik bathi lan rasio pasar:

GALT - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep Galectin Therapeutics|GALT - Kapitalisasi marang bathi|Pangali Forward P/E Galectin Therapeutics|GALT - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Galectin Therapeutics, Inc.|GALT - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Galectin Therapeutics|GALT - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan galectintherapeutics.com|GALT - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Galectin Therapeutics

- data pendapatan lan penerimaan dodolan:

GALT - Pendapatan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Galectin Therapeutics|GALT - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Galectin Therapeutics, Inc.

Pambiji fundamental:Galectin Therapeutics Inc.

The development of new drugs by Galectin Therapeutics (GALT) requires stable supply chains for components from Asia. Expected profits from these processes are compared with current market value to calculate the forward P/E. This metric assesses the cost per unit of future earnings, eliminating overpayment driven by unjustified optimism. The current value of 0.00 reflects market expectations regarding the effectiveness of clinical trials. By analyzing the company's future P/E multiple, an investor determines the degree of the asset's fundamental overvaluation.

Analisis pesaing

Prakiraan rega marang bathi ARWR (Arrowhead Pharmaceuticals, Inc.)|MIRM (Mirum Pharmaceuticals, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep dynavax.com DVAX|Tekmira Pharmaceuticals - Rega marang bathi mangsa ngarep|Inventiva S.A. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi gyretx.com GYRE|ASMB (Assembly Biosciences, Inc.) - Prakiraan rega marang bathi|GNFT (GENFIT) - Rega marang bathi mangsa ngarep|DRRX (DURECT Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Aligos ALGS|Rega marang bathi mangsa ngarep BioVie Inc. (BIVI)|GLMD (galmedpharma.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E NDRA (ENDRA Life Sciences Inc.)|Pangali forward rega marang bathi Hepion Pharmaceuticals Inc.